FDA has approved sarilumab (Kevzara) for the treatment of polymyalgia rheumatica (PMR) in adult patients who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper. Approval is based on Phase 3 SAPHYR study https://t.co/7GHG2uG9yQ https://t.co/MZ7RYGdDfG

• https://bit.ly/3EWwAx6

Triad of Trouble: A case of joint, skin and GI woes Sara Faghihi Kashani, MD, presents her poster at RWCS 2023 https://t.co/xwT2jV1gJv https://t.co/g63tRHsoQY

• https://bit.ly/3SJgZq8

Sarilumab is FDA Approved for PMR The FDA approved sarilumab for PMR, stipulating it is indicated in those patients who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper. https://t.co/VjzloCbpBv https://t.co/9dVb6sVbph

• https://bit.ly/3KOs4o4

"My eye is swollen": an underrecognized mimic of IgG4-related disease Artem Minalyan, MD, presenting his poster at RWCS 2023. https://t.co/1j3FMazdyk https://t.co/K7VoQHhhGz

• https://bit.ly/3mnud00

Without head-to-head trials, do we look to metanalyses? 13 trials of TNF inhibitors in JIA pts - Results at 12-14 weeks. While it ADA looks possibly better, that would be an over-interpretation and misuse of trial data that isnt truly comparable https://t.co/k6QcPZZj67 https://t.co/SwwND1VFfT

• https://bit.ly/3EQOvFA

51 Juvenile SLE (j-SLE) studied for neuropsychiatric Dz (j-NPSLE)- 39% presented with jNPSLE. While no clear biomarker/imaging of j-NPSLE identified, they found CSF neopterin (& IFN-α) levels signif higher w/ active j-NPSLE & CNS involvement (p=0.0008) https://t.co/QM8yJGrBJu https://t.co/4hj1eE2JIC

• https://bit.ly/3ZwhLcl

Study of 87 pts with isolated Nail Psoriasis noted that 11% went on to have #PsA (concurrently or within 3 years). NP findings were mainly onycholysis in79% and nail pitting in 70% https://t.co/2NynITxe6B https://t.co/qs4uYySjxp

• https://wb.md/3YaS6VK

Mycobacterium Tuberculosis Osteomyelitis in a Patient on Pembrolizumab Jourdan Frankovich, MD, presents her poster at RWCS 2023. https://t.co/198oMm7GRa https://t.co/Qnh1sOOl6s

• https://bit.ly/3J3Jf3y